Gsk Full Year Results 2025 Lok. Gsk (gsk) announced its q4 2023 results, exceeding estimates with a 15% yoy growth in sales and citing 12 major product launches from 2025. Under emma walmsley, chief executive since 2017, gsk has struggled to.

Cash generated from operations expected to exceed £10 billion by 2026. Earnings growth is expected to be between 6% and 9% for the year, with a total dividend of 60p being paid, up from 58p in the year just ended.